Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a zoom program help rural breast cancer survivors protect their hearts?

NCT ID NCT07426952

First seen Feb 28, 2026 · Last updated Jun 21, 2026 · Updated 14 times

Summary

This study is testing a 12-week online program called WeCan-Rural for breast cancer survivors living in rural, underserved communities. The program aims to help manage symptoms like pain and fatigue while building healthy habits around eating, exercise, and weight management to lower heart disease risk. Forty women who have completed cancer treatment will be randomly assigned to either the program or standard health information. The main goal is to see if the program is acceptable and helpful to participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Maria Parham Cancer Center

    Henderson, North Carolina, 27536, United States

  • Scotland Health

    Laurinburg, North Carolina, 28352, United States

  • UNC Health Southeastern

    Lumberton, North Carolina, 28358, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

WeCan-Rural Program (behavioral intervention via Zoom sessions)

What this could lead to

If it works, this could point toward a practical way to help breast cancer survivors in rural areas reduce heart disease risk and manage symptoms.

What could go wrong

This is a very small pilot study (40 people) that is currently suspended. It focuses on feasibility and acceptability, not on proving health outcomes, so results may not be generalizable.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.